Hyundai Pharmaceutical Co., Ltd. (004310.KS)
004310.KS Stock Price Chart
Explore Hyundai Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 004310.KS price movements and trends.
004310.KS Company Profile
Discover essential business fundamentals and corporate details for Hyundai Pharmaceutical Co., Ltd. (004310.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Feb 2000
Employees
385.00
Website
https://www.hyundaipharm.co.krCEO
Sang-Jun Lee
Description
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and eye vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others. The company was founded in 1965 and is headquartered in Seoul, South Korea.
004310.KS Financial Timeline
Browse a chronological timeline of Hyundai Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 4 Mar 2025
A dividend of ₩30.00 per share was announced, adjusted to ₩30.00. The dividend was paid on 25 Mar 2025.
Earnings released on 28 Feb 2025
EPS came in at -₩37.70 , while revenue for the quarter reached ₩43.09B .
Earnings released on 30 Nov 2024
EPS came in at -₩57.63 , while revenue for the quarter reached ₩42.86B .
Earnings released on 30 Aug 2024
EPS came in at -₩19.00 , while revenue for the quarter reached ₩46.22B .
Earnings released on 30 May 2024
EPS came in at ₩41.25 , while revenue for the quarter reached ₩43.88B .
Dividend declared on 5 Mar 2024
A dividend of ₩35.00 per share was announced, adjusted to ₩35.00. The dividend was paid on 27 Mar 2024.
Earnings released on 28 Feb 2024
EPS came in at ₩11.64 , while revenue for the quarter reached ₩42.77B .
Earnings released on 23 Feb 2024
EPS came in at ₩64.94 , while revenue for the quarter reached ₩47.45B .
Earnings released on 30 Nov 2023
EPS came in at ₩2.58 , while revenue for the quarter reached ₩45.57B .
Earnings released on 31 May 2023
EPS came in at ₩113.60 , while revenue for the quarter reached ₩48.85B .
Earnings released on 28 Feb 2023
EPS came in at ₩60.79 , while revenue for the quarter reached ₩38.89B .
Earnings released on 30 Nov 2022
EPS came in at -₩221.08 , while revenue for the quarter reached ₩41.16B .
Dividend declared on 29 Nov 2022
A dividend of ₩30.00 per share was announced, adjusted to ₩30.00. The dividend was paid on 22 Mar 2023.
Earnings released on 31 Aug 2022
EPS came in at ₩86.78 , while revenue for the quarter reached ₩42.85B .
Earnings released on 31 May 2022
EPS came in at ₩86.28 , while revenue for the quarter reached ₩41.23B .
Earnings released on 28 Feb 2022
EPS came in at ₩42.00 , while revenue for the quarter reached ₩37.45B .
Earnings released on 30 Nov 2021
EPS came in at -₩84.17 , while revenue for the quarter reached ₩33.80B .
Dividend declared on 29 Nov 2021
A dividend of ₩30.00 per share was announced, adjusted to ₩30.00. The dividend was paid on 23 Mar 2022.
Earnings released on 31 Aug 2021
EPS came in at -₩8.00 , while revenue for the quarter reached ₩38.28B .
Earnings released on 31 May 2021
EPS came in at ₩16.00 , while revenue for the quarter reached ₩37.30B .
Earnings released on 28 Feb 2021
EPS came in at -₩35.00 , while revenue for the quarter reached ₩30.42B .
Earnings released on 30 Nov 2020
EPS came in at ₩1.77 , while revenue for the quarter reached ₩33.27B .
Dividend declared on 27 Nov 2020
A dividend of ₩42.50 per share was announced, adjusted to ₩42.50. The dividend was paid on 23 Mar 2021.
004310.KS Stock Performance
Access detailed 004310.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.